Erratum to Factors Effecting the Morphology of Eudragit S-100 Based Microsponges Bearing Dicyclomine for Colonic Delivery Journal of Pharmaceutical Sciences volume 100 Issue 4 (2011) 1545–1552 (Factors Effecting the Morphology of Eudragit S-100 Based Microsponges Bearing Dicyclomine for Colonic Delivery (2011) 100(4) (1545–1552), (S0022354915321948), (10.1002/jps.22360)): [Journal of Pharmaceutical Sciences volume 100 Issue 4 (2011) 1545–1552];Factors effecting the morphology of eudragit S-100 based microsponges bearing dicyclomine for colonic delivery

Journal of Pharmaceutical Sciences

Volumn 100, Issue 4, 2011, Pages 1545-1552

  Jain, Vikas ^a   Jain, Deepika ^a   Singh, Ranjit ^a  

^a SHOBHIT UNIVERSITY   (India)

Author keywords

Calorimetry (DSC); Colonic drug delivery; Diffusion; FTIR; Gastrointestinal transit

Indexed keywords

DICYCLOVERINE; EUDRAGIT; HYDROXYPROPYLMETHYLCELLULOSE; PECTIN; DRUG CARRIER; ENTERIC COATED TABLET; METHYLMETHACRYLATE-METHACRYLIC ACID COPOLYMER; MUSCARINIC RECEPTOR BLOCKING AGENT; POLYMETHACRYLIC ACID DERIVATIVE;

ARTICLE; COLON; DIFFERENTIAL SCANNING CALORIMETRY; DIFFUSION; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SOLUBILITY; DRUG SYNTHESIS; GASTROINTESTINAL TRANSIT; HUMAN; INFRARED SPECTROSCOPY; MICROEMULSION; MICROENCAPSULATION; NONHUMAN; PARTICLE SIZE; PROCESS OPTIMIZATION; SCANNING ELECTRON MICROSCOPY; TABLET FORMULATION; CHEMISTRY; ENTERIC COATED TABLET; METABOLISM;

COLON; DICYCLOMINE; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; HYPROMELLOSE DERIVATIVES; MUSCARINIC ANTAGONISTS; PECTINS; POLYMETHACRYLIC ACIDS; TABLETS, ENTERIC-COATED;

EID: 79951901317     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1016/j.xphs.2023.07.011     Document Type: Erratum

References (23)

1. Kraneveld AD, Rijinierse A, Nijkamp FP, Garssen J. 2008. Neuro-immune interaction in inflammatory bowel disease and irritable bowel syndrome: Future therapeutic targets. Eur J Pharmacol 585:361-374.
2. McBeth J, Nicholl BI, Musleh M. 2008. Psychosocial risk markers for new onset irritable syndrome-result of a large prospective population-based study. Pain 137:147-155.
3. Paharia A, Yadav AK, Rai G, Jain SK, Pancholi SS, Agrawal GP. 2007. Eudragit-coated pectin microspheres of 5-fluorouracil for colon targating. AAPS Pharma Sci Tech 8:E1-E7.
4. Varshosaz J, Dehkordi AJ, Golanfshan S. 2006. Colon-specific delivery of mesalazine chitosan microspheres. J Microencapsulation 23: 329-339.
5. Kinget R, Kalale W, Vervoort L, Mooter GV. 1998. Colonic drug delivery. J Drug Target 6:129-149.
6. Sinha VR, Kumria R. 2003. Coating polymers for colon specific drug delivery: A comparative in vitro evaluation. Acta Pharm 53:41-47.
7. Chourasia MK, Jain SK. 2003. Pharmaceutical approaches to colon targeted drug delivery systems. J Pharm Pharmaceut Sci 6:33-56.
8. Orlu M, Cevher E, Araman A. 2006. Design and evaluation of colon specific drug delivery system containing flurbiprofen microsponges. Int J Pharm 318: 103-117.
9. Kosaraju SL. 2005. Colon targeted delivery systems: Review of polysaccharides for encapsulation and delivery. Crit Rev Food Sci Nutr 45:251-258.
10. Rubinstein A. 2000. Natural polysaccharides as targeting tools of drugs to the human colon. Drug Dev Res 50:435-443.
11. Vandamme TH, Lenourry A, Charroeau C, Chaumeil JC. 2002. The use of polysaccharides to target drugs to the colon. Carbohydr Polym 48:219-231.
12. Nokhodchi A, Jelvehgari M, Siahi MR, Mozafari MR. 2007. Factors affecting the morphology of benzoyl peroxide microsponges. Micron 38:834-840.
13. Jelvehgari M, Siahi-Shadbad MR, Azarmi S, Martin GP, Nokhodchi A. 2006. The microsponge delivery system of benzoyl peroxide: Preparation, characterization and release studies. Int J Pharm 308:124-132.
14. Sethi PD. 2008. Quantitative analysis of drugs in pharmaceutical formulations. New Delhi, India: CBS publishers and distributors.
15. Kawashima Y, Niwa T, Takeuchi H, Hino T, Ito Y. 1992. Control of prolonged drug release and compression properties of ibuprofen microsponges with acrylic polymer, eudragit RS by changing their intrapartical porosity. Chem Pharm Bul 40:196-201.
16. Comoǧlu T, Gönül N, Baykara T. 2003. Preparation and in vitro evaluation of modified release ketoprofen microsponges. Il Farmaco 58:101-106.
17. Chourasia MK, Jain SK. 2004. Design and development of multiparticulate system fort targeted drug delivery to colon. Drug Deliv 11: 201-207.
18. Perumal D. 2001. Microencapsulation of ibuprofen and Eudragit® S 100 by the emulsion solvent diffusion technique. Int J Pharm 218:1-11.
19. Yang M, Cui F, You B, Fan Y. 2003. Preparation of sustained-release nitrendipine microspheres with Eudragit RS and Aerosil using quasi-emulsion solvent diffusion method. Int J Pharm 259: 103-113.
20. Devrim B, Canefe K. 2006. Preparation and evaluation of modified release ibuprofen microspheres with acrylic polymers (eudragit®) by quasi emulsion solvent diffusion method: Effect of variables. Acta Poloniae Pharmaceutica and Drug Res 63: 521-534.
21. Mukherjeea B, Mahapatraa S, Guptab R, Patraa B, Tiwarib A, Arora P. 2005. A comparison between povidone-ethylcellulose and povidone-eudragit transdermal dexamethasone matrix patches based on in vitro skin permeation. Eur J Pharm Biopharm 59:475-483.
22. Ceschel GC, Badiello R, Ronchi C, Maffei P. 2003. Degradation of components in drug formulations: A comparison between HPLC and DSC methods. J Pharm Biomed Anal 32:1067-1072.
23. Mastiholimath VS, Dandagi PM, Jain SS, Gadad AP, Kulkarni AR. 2007. Time and pH dependent colon specific, pulsatile delivery of theophylline for noctural asthma. Int J Pharm 328:49-56.